Biomarker Technologies Market To Surpass USD 129.5 Billion By 2027 At A CAGR Of 12.7%
The report analyzes and forecasts the Biomarker Technologies Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Biomarker Technologies Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Biomarker Technologies Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Biomarker Technologies Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/1945
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
The players profiled in the report include Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), F. Hoffmann-La Roche AG, Illumina, Inc., LI-COR, Inc., Merck KGAA, PerkinElmer Inc., QIAGEN, Roche (Switzerland), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), and Waters Corporation (US).
The major market segments of Biomarker Technologies Market are as below:
Market By Test Type
Solid Biopsy
Liquid Biopsy
Market By Product
Consumables
Instruments
Services
Software/Informatics
Market By Technology
ddPCR
NGS
Immunoassay
Mass Spectrometry
DHPLC
Other Technologies
Market By Application
Drug Discovery
Diagnostics
Personalized Medicine
Market By Indication
Cancer
Infectious Diseases
Autoimmune Disorders
Cardiovascular Disorders
Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1.Industry Overview of Biomarker Technologies
1.1.Definition and Scope
1.1.1.Definition of Biomarker Technologies
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Biomarker Technologies Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Biomarker Technologies Market By Product
1.2.3.Biomarker Technologies Market By Test Type
1.2.4.Biomarker Technologies Market By Technology
1.2.5.Biomarker Technologies Market By Application
1.2.6.Biomarker Technologies Market By Indication
1.2.7.Biomarker Technologies Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Regulatory Compliance
3.6.Competitive Landscape, 2020
3.6.1.Player Positioning Analysis
3.6.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Biomarker Technologies Market By Product
4.1.Introduction
4.2.Biomarker Technologies Revenue By Product
4.2.1.Biomarker Technologies Revenue (US$ Mn) and Forecast, By Product, 2017-2028
4.2.2.Consumables
4.2.2.1.Consumables Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
4.2.3.Instruments
4.2.3.1.Instruments Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
4.2.4.Services
4.2.4.1.Services Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
4.2.5.Software/Informatics
4.2.5.1.Software/Informatics Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 5.Biomarker Technologies Market Revenue By Test Type
5.1.Introduction
5.2.Biomarker Technologies Revenue (US$ Mn) By Test Type
5.2.1.Biomarker Technologies Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
5.2.2.Solid Biopsy
5.2.2.1.Solid Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.Liquid Biopsy
5.2.3.1.Liquid Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6.Biomarker Technologies Market By Technology
6.1.Introduction
6.2.Biomarker Technologies Revenue (US$ Mn) By Technology
6.2.1.Biomarker Technologies Revenue (US$ Mn) and Forecast By Technology, 2017-2028
6.2.2.DDPCR
6.2.2.1.DDPCR Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.NGS
6.2.3.1.NGS Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4.Immunoassay
6.2.4.1.Immunoassay Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.5.Mass Spectrometry
6.2.5.1.Mass Spectrometry Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.6.DHPLC
6.2.6.1.DHPLC Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.7.Other Technologies
6.2.7.1.Other Technologies Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7.Biomarker Technologies Market By Application
7.1.Introduction
7.2.Biomarker Technologies Revenue (US$) By Application
7.2.1.Biomarker Technologies Revenue (US$ Mn) and Forecast By Application, 2017-2028
7.3.Drug Discovery
7.3.1.Drug Discovery Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.4.Diagnostics
7.4.1.Diagnostics Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.5.Personalized Medicine
7.5.1.Personalized Medicine Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 8.Biomarker Technologies Market By Indication
8.1.Introduction
8.2.Biomarker Technologies Revenue (US$) By Indication
8.2.1.Biomarker Technologies Revenue (US$ Mn) and Forecast By Indication, 2017-2028
8.3.Cancer
8.3.1.Cancer Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
8.4.Infectious Diseases
8.4.1.Infectious Diseases Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
8.5.Autoimmune Disorders
8.5.1.Autoimmune Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
8.6.Cardiovascular Disorders
8.6.1.Cardiovascular Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
8.7.Others
8.7.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 9.North America Biomarker Technologies Market By Country
9.1.North America Biomarker Technologies Overview
9.2.U.S.
9.2.1.U.S. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.2.2.U.S. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
9.2.3.U.S. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
9.2.4.U.S. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.2.5.U.S. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
9.3.Canada
9.3.1.Canada Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.3.2.Canada Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
9.3.3.Canada Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
9.3.4.Canada Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.3.5.Canada Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
9.4.North America PEST Analysis
CHAPTER 10.Europe Biomarker Technologies Market By Country
10.1.Europe Biomarker Technologies Market Overview
10.2.U.K.
10.2.1.U.K. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
10.2.2.U.K. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
10.2.3.U.K. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
10.2.4.U.K. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
10.2.5.U.K. Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.3.Germany
10.3.1.Germany Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
10.3.2.Germany Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
10.3.3.Germany Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
10.3.4.Germany Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
10.3.5.Germany Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.4.France
10.4.1.France Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
10.4.2.France Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
10.4.3.France Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
10.4.4.France Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
10.4.5.France Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.5.Spain
10.5.1.Spain Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
10.5.2.Spain Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
10.5.3.Spain Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
10.5.4.Spain Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
10.5.5.Spain Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.6.Rest of Europe
10.6.1.Rest of Europe Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
10.6.2.Rest of Europe Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
10.6.3.Rest of Europe Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
10.6.4.Rest of Europe Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
10.6.5.Rest of Europe Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
10.7.Europe PEST Analysis
CHAPTER 11.Asia Pacific Biomarker Technologies Market By Country
11.1.Asia Pacific Biomarker Technologies Market Overview
11.2.China
11.2.1.China Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
11.2.2.China Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
11.2.3.China Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
11.2.4.China Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
11.2.5.China Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.3.Japan
11.3.1.Japan Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
11.3.2.Japan Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
11.3.3.Japan Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
11.3.4.Japan Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
11.3.5.Japan Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.4.India
11.4.1.India Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
11.4.2.India Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
11.4.3.India Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
11.4.4.India Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
11.4.5.India Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.5.Australia
11.5.1.Australia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
11.5.2.Australia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
11.5.3.Australia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
11.5.4.Australia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
11.5.5.Australia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.6.South Korea
11.6.1.South Korea Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
11.6.2.South Korea Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
11.6.3.South Korea Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
11.6.4.South Korea Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
11.6.5.South Korea Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.7.Rest of Asia-Pacific
11.7.1.Rest of Asia-Pacific Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
11.7.2.Rest of Asia-Pacific Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
11.7.3.Rest of Asia-Pacific Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
11.7.4.Rest of Asia-Pacific Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
11.7.5.Rest of Asia-Pacific Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
11.8.Asia Pacific PEST Analysis
CHAPTER 12.Latin America Biomarker Technologies Market By Country
12.1.Latin America Biomarker Technologies Market Overview
12.2.Brazil
12.2.1.Brazil Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
12.2.2.Brazil Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
12.2.3.Brazil Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
12.2.4.Brazil Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
12.2.5.Brazil Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
12.3.Mexico
12.3.1.Mexico Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
12.3.2.Mexico Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
12.3.3.Mexico Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
12.3.4.Mexico Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
12.3.5.Mexico Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
12.4.Rest of Latin America
12.4.1.Rest of Latin America Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
12.4.2.Rest of Latin America Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
12.4.3.Rest of Latin America Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
12.4.4.Rest of Latin America Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
12.4.5.Rest of Latin America Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
12.5.Latin America PEST Analysis
CHAPTER 13.Middle East & Africa Biomarker Technologies Market By Country
13.1.Middle East & Africa Biomarker Technologies Market Overview
13.2.Saudi Arabia
13.2.1.Saudi Arabia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
13.2.2.Saudi Arabia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
13.2.3.Saudi Arabia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
13.2.4.Saudi Arabia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
13.2.5.Saudi Arabia Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
13.3.South Africa
13.3.1.South Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
13.3.2.South Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
13.3.3.South Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
13.3.4.South Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
13.3.5.South Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
13.4.Rest of Middle East & Africa
13.4.1.Rest of Middle East & Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
13.4.2.Rest of Middle East & Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Test Type, 2017-2028
13.4.3.Rest of Middle East & Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Technology, 2017-2028
13.4.4.Rest of Middle East & Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
13.4.5.Rest of Middle East & Africa Biomarker Technologies Market Revenue (US$ Mn) and Forecast By Indication, 2017-2028
13.5.Middle East & Africa PEST Analysis
CHAPTER 14.Player Analysis Of Biomarker Technologies
14.1.Biomarker Technologies Market Company Share Analysis
14.2.Competition Matrix
14.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2.New Product Launches and Product Enhancements
14.2.3.Mergers And Acquisition In Global Biomarker Technologies Market
14.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15.Company Profile
15.1.Agilent Technologies
15.1.1.Company Snapshot
15.1.2.Business Overview
15.1.3.Financial Overview
15.1.3.1.Revenue (US$ Mn), 2020
15.1.3.2.Agilent Technologies 2020 Biomarker Technologies Business Regional Distribution
15.1.4.Product/ Service and Specification
15.1.5.Recent Developments & Business Strategy
15.1.6.Manufacturing Plant Footprint Analysis
15.2.Bio-Rad Laboratories, Danaher Corporation
15.3.F. Hoffmann-La Roche AG
15.4.Illumina, Inc.
15.5.LI-COR, Inc.
15.6.Merck KGAA
15.7.PerkinElmer Inc.
15.8.QIAGEN
15.9.Roche
15.10.Shimadzu Corporation
15.11.Thermo Fisher Scientific
15.12.Waters Corporation
15.13.Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/1945
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
